Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Melanoma Stage IV”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT02828202
What this trial is testing

Follow-up of a National Cohort of Melanoma Resectable Stage II, Stage III or IV Patients or Unresectable Primary

Who this might be right for
Malignant Melanoma
Assistance Publique - Hôpitaux de Paris 6,000
Testing effectiveness (Phase 2)UnknownNCT02625337
What this trial is testing

Study Comparing Pembrolizumab With Dual MAPK Pathway Inhibition Plus Pembrolizumab in Melanoma Patients

Who this might be right for
Metastatic Melanoma
The Netherlands Cancer Institute 32
Testing effectiveness (Phase 2)Study completedNCT00257465
What this trial is testing

Trial of Autologous, Hapten-Modified Vaccine in Patients With Stage III or IV Melanoma

Who this might be right for
Melanoma
AVAX Technologies 82
Testing effectiveness (Phase 2)Study completedNCT02076633
What this trial is testing

Intratumoral Administration of L19IL2/L19TNF

Who this might be right for
Malignant Melanoma, Skin
Philogen S.p.A. 21
Testing effectiveness (Phase 2)Active Not RecruitingNCT06101134
What this trial is testing

Evaluate Whether Participants With Melanoma Prefer Subcutaneous vs Intravenous Administration of Nivolumab and Nivolumab + Relatlimab Fixed-dose Combinations

Who this might be right for
Melanoma
Bristol-Myers Squibb 100
Not applicableStudy completedNCT03518814
What this trial is testing

Quality of Life in Patients With Multimetastatic Melanoma Currently in Remission (QUALM)

Who this might be right for
Melanoma (Skin) Stage IVRemission
Lille Catholic University 40
Not applicableStudy completedNCT03290677
What this trial is testing

Study of Core Needle Biopsy and Cryoablation of an Enlarging Tumor in Patients With Metastatic Lung Cancer and Metastatic Melanoma Receiving Post-progression Immune Checkpoint Inhibitor Therapy

Who this might be right for
Lung Cancer
Massachusetts General Hospital 30
Large-scale testing (Phase 3)Ended earlyNCT00020839
What this trial is testing

Temozolomide With or Without Radiation Therapy to the Brain in Treating Patients With Stage IV Melanoma That Is Metastatic to the Brain

Who this might be right for
Melanoma (Skin)Metastatic Cancer
European Organisation for Research and Treatment of Cancer - EORTC 23
Early research (Phase 1)UnknownNCT02619058
What this trial is testing

A Clinical Trial of Adoptive Transfer With Autologous NKT Cells in Metastatic Melanoma Patients

Who this might be right for
Melanoma
Peking University Cancer Hospital & Institute 20
Testing effectiveness (Phase 2)WithdrawnNCT02065466
What this trial is testing

Combo of Abraxane, TMZ, Bevacizumab in Metastatic Melanoma With Brain Metastases

Who this might be right for
Metastatic MelanomaBrain Metastases
University of Arizona
Large-scale testing (Phase 3)Study completedNCT01844505
What this trial is testing

Phase 3 Study of Nivolumab or Nivolumab Plus Ipilimumab Versus Ipilimumab Alone in Previously Untreated Advanced Melanoma (CheckMate 067)

Who this might be right for
Unresectable or Metastatic Melanoma
Bristol-Myers Squibb 945
Early research (Phase 1)UnknownNCT02608437
What this trial is testing

A Study Investigating SGI-110 in Combination With Ipilimumab in Unresectable or Metastatic Melanoma Patients

Who this might be right for
Metastatic Melanoma
Italian Network for Tumor Biotherapy Foundation 19
Testing effectiveness (Phase 2)Looking for participantsNCT03340129
What this trial is testing

Anti-PD 1 Brain Collaboration + Radiotherapy Extension (ABC-X Study)

Who this might be right for
Melanoma Stage Iv
Melanoma Institute Australia 218
Testing effectiveness (Phase 2)Study completedNCT00204594
What this trial is testing

Local Treatment of Metastatic Melanoma With Autologous Lymphocytes and the Bispecific Antibody rM28

Who this might be right for
Malignant Melanoma
University Hospital Tuebingen 1
Very early researchStudy completedNCT02652455
What this trial is testing

Combining PD-1 Blockade, CD137 Agonism and Adoptive Cell Therapy for Metastatic Melanoma

Who this might be right for
Melanoma (Skin)Skin Cancer
H. Lee Moffitt Cancer Center and Research Institute 11
Testing effectiveness (Phase 2)Looking for participantsNCT07686835
What this trial is testing

Dietary Fiber to Induce Gut Microbiota-mediated Response to Immunotherapy in Melanoma.

Who this might be right for
Melanoma (Skin) Stage IVMelanoma (Skin Cancer)Melanoma Metastatic+2 more
Radboud University Medical Center 70
Testing effectiveness (Phase 2)Study completedNCT04526899
What this trial is testing

Investigate the Novel Agent BNT111 and Cemiplimab in Combination or as Single Agents in Patients With Advanced Melanoma That Has Not Responded to Other Forms of Treatment

Who this might be right for
Melanoma Stage IIIMelanoma Stage IVUnresectable Melanoma
BioNTech SE 184
Early research (Phase 1)Study completedNCT00349206
What this trial is testing

Sorafenib and Temsirolimus in Treating Patients With Metastatic, Recurrent, or Unresectable Melanoma

Who this might be right for
MelanomaRecurrent MelanomaStage III Melanoma+1 more
National Cancer Institute (NCI) 69
Early research (Phase 1)Study completedNCT02639026
What this trial is testing

Trial Of Hypofractionated Radiotherapy In Combination With MEDI4736 And Tremelimumab For Patients With Metastatic Melanoma And Lung, Breast And Pancreatic Cancers

Who this might be right for
MetastaticMelanomaNon Small Cell Lung Cancer (NSCLC)+2 more
Abramson Cancer Center at Penn Medicine 53
Testing effectiveness (Phase 2)Ended earlyNCT01692691
What this trial is testing

Dacarbazine and Carmustine in Metastatic Melanoma

Who this might be right for
Melanoma Metastatic
Western Regional Medical Center 1
Next Page